Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

53.50
-0.3650-0.68%
Volume:42.79K
Turnover:2.25M
Market Cap:153.75M
PE:-1.39
High:53.50
Open:53.04
Low:51.80
Close:53.86
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:0.61
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:1.84
PE(LYR):-1.05

Loading ...

Spruce Biosciences names Eric Jordan as VP, Marketing

Reuters
·
Jun 15

Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller

THOMSON REUTERS
·
Jun 15

Spruce Biosciences Initiated at Buy by Jones Trading

Dow Jones
·
Jun 09

Spruce Biosciences Reports Long-Term Data for Enzyme Replacement Therapy to Treat Genetic Disease MPS IIIB

MT Newswires Live
·
Jun 09

Spruce Biosciences initiated with a Buy at JonesResearch

TIPRANKS
·
Jun 09

Spruce says long-term TA-ERT data presented at MPS Symposium

TIPRANKS
·
Jun 09

Spruce Biosciences reports six-year tralesinidase alfa data showing sustained biomarker reductions, stabilized cognition in MPS IIIB

Reuters
·
Jun 09

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (Mps Iiib) Presented at the 18TH International Mps Symposium

THOMSON REUTERS
·
Jun 09

Spruce Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 01

Spruce Biosciences, Inc : H.c. Wainwright Cuts Target Price to $150 From $200

THOMSON REUTERS
·
Jun 01

Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium

Reuters
·
May 29

Spruce Biosciences to present long-term tralesinidase alfa data in Sanfilippo syndrome Type B at International MPS Symposium

Reuters
·
May 29

Spruce Biosciences Announces Data Presentation at the 18TH International Mps Symposium

THOMSON REUTERS
·
May 29

Spruce Biosciences to present at Jefferies Global Healthcare Conference

Reuters
·
May 28

Analysts’ Top Healthcare Picks: Spruce Biosciences (SPRB), CG Oncology, Inc. (CGON)

TIPRANKS
·
May 27

Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay

TIPRANKS
·
May 27

Spruce Biosciences shareholders elect Class III directors at annual meeting

Reuters
·
May 27

Spruce Biosciences, Inc : Leerink Partners Cuts Target Price to $120 From $140

THOMSON REUTERS
·
May 14

Spruce Biosciences Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 14

Spruce Biosciences price target lowered to $150 from $170 at Citizens

TIPRANKS
·
May 14